Axonics, Inc.·4

Jul 25, 7:33 PM ET

COHEN RAYMOND W 4

4 · Axonics, Inc. · Filed Jul 25, 2024

Insider Transaction Report

Form 4
Period: 2024-07-24
COHEN RAYMOND W
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-07-24$14.19/sh+25,771$365,690214,606 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-07-2425,771196,451 total
    Exercise: $14.19Exp: 2029-01-30Common Stock (25,771 underlying)
  • Exercise/Conversion

    Common Stock

    2024-07-24$25.82/sh+78,125$2,017,188292,731 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-07-2478,1250 total
    Exercise: $25.82Exp: 2029-12-12Common Stock (78,125 underlying)
Footnotes (2)
  • [F1]These options were granted on December 12, 2019 and are fully vested.
  • [F2]These options were granted on January 30, 2019 and are fully vested.

Documents

2 files